Shotlee LogoShotlee
Blog
Skip to main content
AllOzempicMounjaroRetatrutideGLP-1 MedicationsWeight ManagementHealth & WellnessWeight LossMetabolic Health

Latest Articles

Latest Articles

Showing 9 / 872 Weight Management articles

Study Explores Plant-Based Platform for Oral GLP-1 Therapies
GLP-1 Medications

Study Explores Plant-Based Platform for Oral GLP-1 Therapies

A pioneering study led by Henry Daniell at Penn Dental Medicine has engineered lettuce chloroplasts to produce functional exenatide and lixisenatide, offering a plant-based path to oral GLP-1 therapies. This approach addresses key barriers like stomach degradation and high costs, potentially transforming diabetes and obesity treatment. Patients may soon swap weekly injections for simple lettuce-based pills.

Shotlee··6 min read
Wegovy and Ozempic May Slash Deadly Heart Attack Complication Risk
GLP-1 Medications

Wegovy and Ozempic May Slash Deadly Heart Attack Complication Risk

Researchers from the University of Bristol and UCL have found that GLP-1 drugs like Wegovy and Ozempic could dramatically reduce the risk of 'no-reflow,' a deadly complication affecting up to half of heart attack patients. By relaxing tiny blood vessels, these medications may prevent further heart damage even if given by paramedics on-site. This study opens doors for repurposing popular obesity and diabetes treatments in emergency cardiac care.

Shotlee··6 min read
Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending
GLP-1 Medications

Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending

A new Leger Healthcare survey estimates that around three million Canadian adults are currently using GLP-1 medications such as Ozempic or Mounjaro. These drugs are not only curbing appetite and cravings but also transforming daily spending habits, from less restaurant takeout to more fresh produce and gym memberships. Weight loss tops the reasons, but barriers like cost keep millions from starting.

Shotlee··5 min read